2B30 Intrinsic Valuation and Fundamental Analysis - Xeris Biopharma Holdings Inc

	Xeris Biopharma Holdings Inc F:2B30	US
	Lifecare AS F:LFC	NO
N	Nanosonics Ltd F:OQS	AU
G	Gorman-Rupp Co F:GO4	US
C	Contact Energy Ltd F:BZB	NZ
T	Tripadvisor Inc XMUN:T6A	US

Intrinsic Value

The intrinsic value for Xeris Biopharma Holdings Inc (2B30) under the Base Case is hidden EUR. Compared with the current market price of 7.202 EUR, the stock appears hidden .

DCF Value

Locked

Multiples-Based Value

Locked

DCF Value

Locked

Multiples-Based Value

Locked

Why combine DCF with multiples? What is Intrinsic Value?

2B30 Intrinsic Value

Unlock

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price €7.2

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

2B30 looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 2B30 usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Xeris Biopharma Holdings Inc.

Explain Valuation